ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AVXL Anavex Life Sciences Corporation

4,17
-0,33 (-7,33%)
Após o horário de negociação
Última atualização: 17:25:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Anavex Life Sciences Corporation AVXL NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,33 -7,33% 4,17 17:25:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,50 4,105 4,51 4,17 4,50
mais cotações »

Notícias Recentes

Data Hora Fonte Título
22/05/202408:30GLOBEAnavex Life Sciences Announces Expansion of Leadership Team
14/05/202408:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 2nd..
10/05/202406:45PRNUSShareholders that lost money on Anavex Life Sciences..
09/05/202408:30GLOBEAnavex Life Sciences Reports Fiscal 2024 Second Quarter..
07/05/202406:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
03/05/202406:45PRNUSAnavex Life Sciences Corporation Sued for Securities Law..
02/05/202408:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 Second Quarter..
26/04/202406:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/04/202406:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/04/202406:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/04/202406:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/04/202408:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/04/202406:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/04/202406:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/04/202406:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/03/202406:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/03/202406:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/03/202408:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/03/202406:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/03/202408:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/02/202409:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
07/02/202409:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/02/202409:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
24/01/202409:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
16/01/202409:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
08/01/202409:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
03/01/202409:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
02/01/202410:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
20/12/202309:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
19/12/202309:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
27/11/202310:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
27/11/202308:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
24/11/202310:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
22/11/202310:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
20/11/202310:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
06/11/202310:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
25/10/202309:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
14/09/202308:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
12/09/202308:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
08/08/202308:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
07/08/202308:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
02/08/202308:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
01/08/202308:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
28/06/202308:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
27/06/202308:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
20/06/202308:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
15/06/202308:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..
12/06/202308:30GLOBEAnavex Life Sciences Reports Publication in Medical Journal..
06/06/202308:30GLOBEAnavex Life Sciences Announces Completion of ANAVEX(®)2-73..
01/06/202308:30GLOBEANAVEX Announces Issuance of New U.S. Intellectual Property..